Neuroleptic malignant syndrome.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013577:Syndrome
D014150:Antipsychotic Agents; D003402:Creatine Kinase